Matches in SemOpenAlex for { <https://semopenalex.org/work/W2419259168> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2419259168 endingPage "60" @default.
- W2419259168 startingPage "3955" @default.
- W2419259168 abstract "To observe the one-year neurologic prognostic outcome of newborns with moderate and severe hypoxic-ischemic encephalopathy (HIE) who received recombinant human erythropoietin (rhuEPO) combined with exogenous monosialotetrahexosylganglioside (GM1) treatment to provide new guidelines for clinical treatment.Seventy-six newborns with moderate and severe HIE were selected from February 2011 to February 2014 in our hospital. This study received the informed consent of our hospital's Ethics Committee and the newborns' guardians. The newborns were divided to an observation group (n = 34 cases) and a control group (n = 42 cases). All newborns underwent hypothermia and conventional treatment for their conditions. The control group received GMl treatment and observation group received rhuEPO combined with GMl treatment. The curative differences and neural behavior from these two groups were compared.The excellent, efficient proportion and total effective rate of the newborns from the observation group were higher than the control group. The death rate, cerebral palsy and the invalid ratio of the newborns from the observation group were lower than that of the control group. Awareness, muscle tension, primitive reflex and increased intracranial pressure recovery time of the newborns in the observation group were less than those of the control group. The Neonatal Behavior Neurological Assessment (NBNA) score of both groups after the treatment of 7, 14 and 28 days were significantly higher and increased with time (p < 0.05). The MDI, PDI and DQ score of newborns from the two groups all increased after treatment of 3, 6 and 12 months than those of before, which increased with time (p < 0.05).The rhuEPO + GMl treatment in newborns with HIE improves short-term clinical effects and long-term neurological symptoms." @default.
- W2419259168 created "2016-06-24" @default.
- W2419259168 creator A5007532295 @default.
- W2419259168 creator A5010165140 @default.
- W2419259168 creator A5011029452 @default.
- W2419259168 creator A5037624447 @default.
- W2419259168 creator A5041272263 @default.
- W2419259168 creator A5055410869 @default.
- W2419259168 creator A5075417784 @default.
- W2419259168 date "2015-10-01" @default.
- W2419259168 modified "2023-09-27" @default.
- W2419259168 title "Influence of one-year neurologic outcome of treatment on newborns with moderate and severe hypoxic-ischemic encephalopathy by rhuEP0 combined with ganglioside (GM1)." @default.
- W2419259168 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26531285" @default.
- W2419259168 hasPublicationYear "2015" @default.
- W2419259168 type Work @default.
- W2419259168 sameAs 2419259168 @default.
- W2419259168 citedByCount "3" @default.
- W2419259168 countsByYear W24192591682017 @default.
- W2419259168 countsByYear W24192591682020 @default.
- W2419259168 crossrefType "journal-article" @default.
- W2419259168 hasAuthorship W2419259168A5007532295 @default.
- W2419259168 hasAuthorship W2419259168A5010165140 @default.
- W2419259168 hasAuthorship W2419259168A5011029452 @default.
- W2419259168 hasAuthorship W2419259168A5037624447 @default.
- W2419259168 hasAuthorship W2419259168A5041272263 @default.
- W2419259168 hasAuthorship W2419259168A5055410869 @default.
- W2419259168 hasAuthorship W2419259168A5075417784 @default.
- W2419259168 hasConcept C126322002 @default.
- W2419259168 hasConcept C185592680 @default.
- W2419259168 hasConcept C1862650 @default.
- W2419259168 hasConcept C187212893 @default.
- W2419259168 hasConcept C2777331542 @default.
- W2419259168 hasConcept C2777390192 @default.
- W2419259168 hasConcept C2778534260 @default.
- W2419259168 hasConcept C2778621155 @default.
- W2419259168 hasConcept C2779421357 @default.
- W2419259168 hasConcept C2909832856 @default.
- W2419259168 hasConcept C42219234 @default.
- W2419259168 hasConcept C55493867 @default.
- W2419259168 hasConcept C71924100 @default.
- W2419259168 hasConceptScore W2419259168C126322002 @default.
- W2419259168 hasConceptScore W2419259168C185592680 @default.
- W2419259168 hasConceptScore W2419259168C1862650 @default.
- W2419259168 hasConceptScore W2419259168C187212893 @default.
- W2419259168 hasConceptScore W2419259168C2777331542 @default.
- W2419259168 hasConceptScore W2419259168C2777390192 @default.
- W2419259168 hasConceptScore W2419259168C2778534260 @default.
- W2419259168 hasConceptScore W2419259168C2778621155 @default.
- W2419259168 hasConceptScore W2419259168C2779421357 @default.
- W2419259168 hasConceptScore W2419259168C2909832856 @default.
- W2419259168 hasConceptScore W2419259168C42219234 @default.
- W2419259168 hasConceptScore W2419259168C55493867 @default.
- W2419259168 hasConceptScore W2419259168C71924100 @default.
- W2419259168 hasIssue "20" @default.
- W2419259168 hasLocation W24192591681 @default.
- W2419259168 hasOpenAccess W2419259168 @default.
- W2419259168 hasPrimaryLocation W24192591681 @default.
- W2419259168 hasRelatedWork W1985602048 @default.
- W2419259168 hasRelatedWork W2033237312 @default.
- W2419259168 hasRelatedWork W2043480430 @default.
- W2419259168 hasRelatedWork W2242308574 @default.
- W2419259168 hasRelatedWork W2765518338 @default.
- W2419259168 hasRelatedWork W2794370451 @default.
- W2419259168 hasRelatedWork W3008453445 @default.
- W2419259168 hasRelatedWork W3029814991 @default.
- W2419259168 hasRelatedWork W3031593563 @default.
- W2419259168 hasRelatedWork W4200478800 @default.
- W2419259168 hasVolume "19" @default.
- W2419259168 isParatext "false" @default.
- W2419259168 isRetracted "false" @default.
- W2419259168 magId "2419259168" @default.
- W2419259168 workType "article" @default.